CALC
CalciMedica, Inc.
$0.78
+0.04 (+5.04%)
At close · Jul 15
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our need for additional capital raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$10.96M
Shares
15,798,031
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$29.56M
-115.8%
FY2025
Diluted EPS
-$1.97
-61.5%
FY2025
Operating Cash Flow
-$21.18M
-0.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| $617K | $713K | $1.01M | — | — | — | — | — | |
| $14.5M | $15.23M | $14.48M | $15.86M | $8.35M | $18.9M | $20.96M | $30.58M | |
| $7.74M | $7.89M | $9.73M | $22.22M | $5.84M | $17.04M | $8.87M | $6.92M | |
| — | — | — | $58K | $52K | — | — | — | |
| — | — | — | — | $3M | — | — | — | |
| $22.24M | $23.12M | $24.2M | $38.08M | $14.19M | $35.95M | $29.83M | $37.5M | |
| -$22.24M | -$23.12M | -$24.2M | -$38.08M | -$14.19M | -$35.95M | -$29.83M | -$37.5M | |
| $1.29M | $1.42M | $0 | — | — | — | — | — | |
| — | — | — | — | $575K | $126K | $143K | $393K | |
| $2.69M | -$6.44M | $10.5M | $3.72M | $6.37M | — | — | — | |
| — | -$29.56M | -$13.7M | — | — | — | — | — | |
| $0 | $0 | $0 | $1000 | $1000 | — | — | — | |
| -$19.54M | -$29.56M | -$13.7M | -$34.36M | -$7.82M | -$35.82M | -$27.53M | -$37.04M | |
| -$19.54M | -$29.56M | -$13.7M | -$34.36M | -$9.14M | -$35.82M | -$34.72M | -$44.09M | |
| -$19.54M | -$29.57M | -$13.7M | -$34.36M | -$9.14M | -$35.83M | -$27.54M | -$37.03M | |
| USD/shares | — | -$1.97 | -$1.22 | -$7.66 | -$111.16 | -$1.69 | — | — |
| USD/shares | — | -$1.97 | -$1.22 | -$7.66 | -$111.16 | -$1.69 | — | — |
| shares | — | 15.01M | 11.25M | 4.49M | 82.25K | 21.2M | 6.62M | 1.32M |
| shares | — | 15.01M | 11.25M | 4.49M | 82.25K | 21.2M | 6.62M | 1.32M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.53×
EV/EBIT
—
Biotechnology median 26.15×
P/E (TTM)
—
Biotechnology median 7.35×